University of Iowa
Iowa City, Iowa, 52242, United States
Location status: Recruiting
NCT Number: NCT06159608
The use of electronic nicotine delivery systems, or e-cigarettes - colloquially referred to as "vaping" - in the United States has increased exponentially since their introduction to the US market in 2007. Prevalence of ever and current e-cigarette use is highest among teenagers and young adults with 16-28% of this population having reported vaping. While the majority of e-cigarette users are current tobacco smokers, 32.5% of current e-cigarette users are never- or former-smokers, representing a growing population of young adults who exclusively vape. While e-cigarettes have been marketed as a safer alternative to tobacco cigarettes, clinical studies examining these claims are limited. Cardiovascular disease (CVD) is the primary cause of premature death among tobacco cigarette smokers and reductions in vascular endothelial function, a significant predictor of future CVD, are detectible in otherwise healthy young adults who smoke. Despite the explosion in e-cigarette use among young adults, the health effects - especially the effects on mechanisms of vascular function - of these devices remain relatively unexplored.
In this study, we use the blood vessels in the skin as a representative vascular bed for examining mechanisms of microvascular dysfunction in humans. Using a minimally invasive technique (intradermal microdialysis for the local delivery of pharmaceutical agents) we examine the blood vessels in a dime-sized area of the skin in otherwise healthy young (18-24yrs) chronic e-cigarette users. Local heating of the skin at the microdialysis sites is used to explore differences in mechanisms governing microvascular control. As a compliment to these measurements, we also draw blood from the subjects to measure circulating factors that may contribute to cardiovascular health and examine markers of inflammatory activation. We will also collect urine from female participants to measure estradiol.
Interested in participating?
Request Info18 year–24 year
All sexes
Interventional
Early Phase 1
Iowa City, Iowa, 52242, United States
Location status: Recruiting
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Differences in endothelium- and nitric oxide (NO)-dependent dilation between groups
differences in urine estrogen levels across the menstrual cycle between women groups only
Time frame: at the study visit, an average of 4 hours
cutaneous vascular vasodilator responses to local heating over a microdialysis fiber receiving lactated Ringer's solution, followed by L-NAME infusion to quantify NO-dependent response
Time frame: 1 month
daily estradiol levels will be measured in all women for 1 month/menstrual cycle
Contact information is provided by the study sponsor or research team.
Anna Stanhewicz, PhD
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06066996
Behavior, E-cigarette Use
Baltimore, Maryland, United States
View Trial DetailsNCT06929520
Behavior, Chemically-Induced Disorders
Honolulu, Hawaii, United States
View Trial DetailsNCT06372899
Behavior, Cigarette Smoking
Philadelphia, Pennsylvania, United States
View Trial DetailsNCT07161050
Behavior, Cigarette Smoking
Roanoke, Virginia, United States
View Trial Details